IRONWOOD, Mich., July 25, 2017 -- Keweenaw Land Association, Limited (OTC Pink:KEWL) today announced second quarter earnings for the period ending June 30, 2017. The company reported a Net Loss of $273,960, or $0.21 per share, versus Net Loss of $13,053, or $0.01 per share, in the second quarter of 2016. Keweenaw also reported timber sales of $1,671,018 for quarter, down $106,977, or 6%, from the $1,777,995 that the company reported in the comparable period in 2016.
Keweenaw also reported EBITDA Timber Operations Income of $14,648 for the second quarter, down $125,718 or 90%, compared to $140,366 in the same period in 2016. A comprehensive newsletter detailing operating results is available on the company’s website at www.keweenaw.com.
About Keweenaw Land Association, Limited: Keweenaw is a forest products and land management company located in Ironwood, Michigan. Keweenaw has land holdings of approximately 182,500 surface acres and over 400,000 acres of mineral rights, located predominantly in the western Upper Peninsula of Michigan. Keweenaw shares trade in the OTC Markets under the Pink directory with 1,300,174 shares outstanding.
Contact: James J. Simmons, Jr., Controller/Treasurer, Keweenaw Land Association, Limited, 1-906-932-3410


Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Italy Fines Apple €98.6 Million Over App Store Dominance
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 



